about
Estimates of cancer incidence and mortality in China, 2013Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients.Evaluating efficacy of screening for upper gastrointestinal cancer in China: a study protocol for a randomized controlled trial.The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer.Combining thioridazine and loratadine for the treatment of gastrointestinal tumor.MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis.Comparison of cancer incidence and mortality in three GDP per capita levels in China, 2013.Epidemiology of gynecologic cancers in China.MiR-514a-3p inhibits cell proliferation and epithelial-mesenchymal transition by targeting EGFR in clear cell renal cell carcinoma.The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation.Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy.Trends in geographical disparities for cervical cancer mortality in China from 1973 to 2013: a subnational spatio-temporal study.Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014.Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells.Cancer incidence in Beijing, 2014.Cancer incidence and mortality in China, 2014.Global Expression Profiling and Pathway Analysis of Mouse Mammary Tumor Reveals Strain and Stage Specific Dysregulated Pathways in Breast Cancer Progression.Downregulation of HOXA13 sensitizes human esophageal squamous cell carcinoma to chemotherapy.Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma.Tropomyosin-1 promotes cancer cell apoptosis via the p53-mediated mitochondrial pathway in renal cell carcinoma.Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers.Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset.MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer.Aging-related prognosis analysis of definitive radiotherapy for very elderly esophageal cancer.Fine particulate matter associated mortality burden of lung cancer in Hebei Province, China.Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumorsThe Application of Nanoparticle-Based Drug Delivery Systems in Checkpoint Blockade Cancer ImmunotherapyAll-Cause and Cancer Mortality Trends in Macheng, China (1984⁻2013): An Age-Period-Cohort AnalysisNEAT1_2-SFPQ axis mediates cisplatin resistance in liver cancer cells in vitroSerum and Adipose Tissue mRNA Levels of ATF3 and FNDC5/Irisin in Colorectal Cancer Patients With or Without ObesityAnnual cost of illness of stomach and esophageal cancer patients in urban and rural areas in China: A multi-center study
P2860
Q38619604-BD14C2E2-BA99-4493-B24F-1D38F2D81A25Q41623532-FDAAD603-7D29-4769-A80C-FAA4BAC5DC59Q41662322-3611E534-2401-4FFE-8D16-FE025A7F7EFBQ42378461-7AECAF79-0AC8-4F63-AD66-0A67BCDE0904Q43856764-6717C76A-D5B6-495E-AC4D-B9AB0DCDA368Q47100861-5122C986-FC7F-4201-9580-FBF55F8B90F1Q47140425-1A62C4AD-EEDD-4F3D-A31E-0B0D119292D3Q47142333-B6B12399-B243-4B21-AAD2-20812940C16DQ47209993-F88A32EF-122D-4905-83FB-D46B8537C756Q47678239-08F7FA57-B42D-4DAA-B124-9BE80885FFC1Q47808831-D1468DD9-6D7E-49DF-A179-813A42A102A8Q49194033-84B42546-EE53-4C27-B156-C1637C7D488BQ49397879-1ED54F24-C432-40CA-946F-C76EFEA88B99Q49831534-4EA268A4-2D54-44DC-8009-E31637D86928Q51733568-F35B59A2-67BF-419C-8CA8-E4B0FBCD5890Q52653171-D53A850D-E410-47CF-9CBB-98D9E6C010E4Q52715481-12BCC28F-CEE1-4994-BF8D-B15B77568E4CQ53682858-9A3C4320-F112-451D-B7D6-E9027BA62B88Q53834241-5550922F-E716-4426-8A0E-5F90AE28C85FQ55094502-80D6CDCB-3A6C-40A7-8E0E-F2F925A60799Q55209571-F895F961-5F58-444F-951B-C294A492C85FQ55286770-34F282C5-67A5-4292-AD87-A8AFBFE67ADFQ55295074-E74E9981-9E1E-4F62-8F83-C3DB3C4520C0Q55375994-1EF9D222-C306-45AC-A6C2-0712E387BD9AQ55516297-8A3D8E8B-D85A-4B3F-9220-A2F9486347AAQ55717061-CE083570-A13C-45A8-8B72-24CEF66BF45EQ58555853-8A942C79-DA4C-49F4-BA6D-5EB75CF47C60Q58604249-801C748F-1801-4B9A-A9D7-0F5F64371A8EQ58708653-CF093C4D-113F-4201-A055-5526B1F3A7DBQ58750980-F9F93056-9296-4F31-A994-1EDE75FCEC97Q58754098-1376AE11-6315-4624-A2A7-D30D91EB319CQ58804562-18E93B44-9E32-4A39-B884-2B2F81EF81D0
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Cancer incidence and mortality in China, 2013.
@en
type
label
Cancer incidence and mortality in China, 2013.
@en
prefLabel
Cancer incidence and mortality in China, 2013.
@en
P2093
P1433
P1476
Cancer incidence and mortality in China, 2013
@en
P2093
Hongmei Zeng
Rongshou Zheng
Siwei Zhang
Tingting Zuo
Wanqing Chen
Xiaonong Zou
Zhixun Yang
P356
10.1016/J.CANLET.2017.04.024
P407
P50
P577
2017-05-03T00:00:00Z